National Healthcare Properties Valuation
Is HLTC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HLTC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate HLTC's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate HLTC's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HLTC?
Key metric: As HLTC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is HLTC's PS Ratio? | |
|---|---|
| PS Ratio | 0.1x |
| Sales | US$352.84m |
| Market Cap | US$52.72m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.4x |
| Enterprise Value/EBITDA | -49.2x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does HLTC's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.8x | ||
NHHS NorthStar Healthcare Income | 0.7x | n/a | US$148.6m |
DHC Diversified Healthcare Trust | 0.4x | 5.3% | US$588.7m |
UHT Universal Health Realty Income Trust | 5.6x | n/a | US$563.0m |
CHCT Community Healthcare Trust | 4.5x | 12.3% | US$523.3m |
HLTC National Healthcare Properties | 0.1x | n/a | US$52.7m |
Price-To-Sales vs Peers: HLTC is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (2.8x).
Price to Sales Ratio vs Industry
How does HLTC's PS Ratio compare vs other companies in the US Health Care REITs Industry?
| 3 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| Industry Avg. | 5.6x | 8.5% | |
HLTC National Healthcare Properties | 0.1x | n/a | US$52.72m |
DHC Diversified Healthcare Trust | 0.4x | 5.3% | US$588.71m |
GBCS Selectis Health | 0.1x | n/a | US$4.17m |
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
| Industry Avg. | 5.6x | 22.9% | |
HLTC National Healthcare Properties | 0.1x | n/a | US$52.72m |
Price-To-Sales vs Industry: HLTC is good value based on its Price-To-Sales Ratio (0.1x) compared to the US Health Care REITs industry average (5.6x).
Price to Sales Ratio vs Fair Ratio
What is HLTC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.1x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate HLTC's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Innovative Industrial Properties
US$3.0b
A self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities.
IIPR
US$107.12
7D
4.8%
1Y
33.3%
Hudson Pacific Properties
US$441.4m
Hudson Pacific Properties (NYSE: HPP) is a real estate investment trust serving dynamic tech and media tenants in global epicenters for these synergistic, converging and secular growth industries.
HPP
US$3.32
7D
-9.8%
1Y
-37.4%
Boardwalk Real Estate Investment Trust
CA$3.8b
Boardwalk REIT strives to be Canada's friendliest community provider and is a leading owner/operator of multi-family rental communities.
BOWF.F
CA$50.23
7D
2.0%
1Y
5.6%